Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study
Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Deborah Schrag(Dana-Farber Brigham Cancer Center), Mark G. Kris(Memorial Sloan Kettering Cancer Center), Alexia Iasonos(Memorial Sloan Kettering Cancer Center), Ann Culkin(Memorial Sloan Kettering Cancer Center), Howard I. Scher(Memorial Sloan Kettering Cancer Center), Tiffani L. McDonough(Memorial Sloan Kettering Cancer Center)
Cited by 657
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k